Get started
Author

Rekha Rao

Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
2009 · Warren Fiskus, Yongchao Wang, et al. · Blood · 356
PDF
RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas
2012 · Xinwei Zhang, Xiaohong Zhao, et al. · Cancer Cell · 276
PDF
Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia
2014 · Warren Fiskus, Nakhle Saba, et al. · Cancer Research · 248
HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells
2008 · Rekha Rao, Warren Fiskus, et al. · Blood · 188
PDF
Cotreatment with panobinostat and JAK2 inhibitor TG101209 attenuates JAK2V617F levels and signaling and exerts synergistic cytotoxic effects against human myeloproliferative neoplastic cells
2009 · Yongchao Wang, Warren Fiskus, et al. · Blood · 177
PDF
Hydroxamic Acid Analogue Histone Deacetylase Inhibitors Attenuate Estrogen Receptor-α Levels and Transcriptional Activity: A Result of Hyperacetylation and Inhibition of Chaperone Function of Heat Shock Protein 90
2007 · Warren Fiskus, Yuan Ren, et al. · Clinical Cancer Research · 140
Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1
2011 · Ramesh Balusu, Warren Fiskus, et al. · Blood · 133
PDF
Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells
2006 · Warren Fiskus, Michael Pranpat, et al. · Molecular Cancer Therapeutics · 112
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
2012 · Rekha Rao, Ramesh Balusu, et al. · Molecular Cancer Therapeutics · 107
Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells
2006 · Warren Fiskus, Michael Pranpat, et al. · Clinical Cancer Research · 102
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells
2009 · Warren Fiskus, Kate Buckley, et al. · Cancer Biology & Therapy · 97
PDF
Heat Shock Protein 90 Inhibitor Is Synergistic with JAK2 Inhibitor and Overcomes Resistance to JAK2-TKI in Human Myeloproliferative Neoplasm Cells
2011 · Warren Fiskus, Srdan Verstovsek, et al. · Clinical Cancer Research · 96
Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells
2010 · Rekha Rao, Srilatha Nalluri, et al. · Molecular Cancer Therapeutics · 82
Hsp90 Inhibitor–Mediated Disruption of Chaperone Association of ATR with Hsp90 Sensitizes Cancer Cells to DNA Damage
2011 · Kyungsoo Ha, Warren Fiskus, et al. · Molecular Cancer Therapeutics · 81
Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor–resistant acute myeloid leukemia cells
2008 · Warren Fiskus, Rekha Rao, et al. · Blood · 77
PDF
Cotreatment with Vorinostat Enhances Activity of MK-0457 (VX-680) against Acute and Chronic Myelogenous Leukemia Cells
2008 · Warren Fiskus, Yongchao Wang, et al. · Clinical Cancer Research · 68
PDF
Targeting p97 to Disrupt Protein Homeostasis in Cancer
2016 · Pratikkumar Harsukhbhai Vekaria, Trisha Home, et al. · Frontiers in Oncology · 56
PDF
Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists
2010 · Aditya Mandawat, Warren Fiskus, et al. · Blood · 54
Role of CAAT/Enhancer Binding Protein Homologous Protein in Panobinostat-Mediated Potentiation of Bortezomib-Induced Lethal Endoplasmic Reticulum Stress in Mantle Cell Lymphoma Cells
2010 · Rekha Rao, Srilatha Nalluri, et al. · Clinical Cancer Research · 50
PDF
Cotreatment with BCL-2 antagonist sensitizes cutaneous T-cell lymphoma to lethal action of HDAC7-Nur77–based mechanism
2008 · Jianguang Chen, Warren Fiskus, et al. · Blood · 50
Superior Efficacy of a Combined Epigenetic Therapy against Human Mantle Cell Lymphoma Cells
2012 · Warren Fiskus, Rekha Rao, et al. · Clinical Cancer Research · 48
Heat Shock Factor 1 in Protein Homeostasis and Oncogenic Signal Integration
2015 · Trisha Home, Roy A. Jensen, et al. · Cancer Research · 44
HDAC Inhibitors and Chaperone Function
2012 · Rekha Rao, Warren Fiskus, et al. · Advances in cancer research · 44
Targeting HSF1 disrupts HSP90 chaperone function in chronic lymphocytic leukemia
2015 · Siddhartha Ganguly, Trisha Home, et al. · Oncotarget · 37
PDF
Co-treatment with vorinostat synergistically enhances activity of Aurora kinase inhibitor against human breast cancer cells
2012 · Warren Fiskus, Stacey L. Hembruff, et al. · Breast Cancer Research and Treatment · 29
Works count: 84
Citation count: 2,918
H-index: 26
I10-index: 31
Year
Topic
Type